GlaxoSmithKline is seeing a "leveling off of the impact" of Chantix on sales of its behind-the-counter nicotine replacement therapies (NRT) amid concerns about the safety of the smoking cessation drug.

Microsoft's HealthVault has announced a collaboration deal with communications giant AT&T and computer platform service provider Covisint that will allow patients to share medical information with participating doctors via the Internet.

Merck may have to wait until 2013 before the FDA reconsiders approval of its cholesterol drug known as Cordaptive (MK-0524A).

Contract sales firm PDI has announced the retirement of its CEO Michael Marquard.

WebMD is bringing in less ad money and facing increased competition from smaller, similar websites, Wall Street analysts said this week.

Pfizer bought some extra time for its blockbuster cholesterol drug Lipitor (atorvastatin) by reaching a settlement with Ranbaxy Laboratories delaying the US launch of a generic version of the world's top selling pharmaceutical brand.

Although four million people have tried GlaxoSmithKline's OTC weight loss drug Alli during its first year on the market, preliminary sales figures are "pretty underwhelming," one analyst tells the Associated Press.

Revolution Health Group has reduced its staff by 50 employees as the online consumer health company reshuffles for the second time in eight months.

The AIDS Healthcare Foundation launched a print ad aimed at shaming Merck in its own neighborhood for the prices it charges for AIDS drug Stocrin (Sustiva) in Mexico.

US health officials Thursday announced the launch of a new system to better monitor the side effects of marketed pharmaceuticals.